Trials / Terminated
TerminatedNCT01478087
Immunoadsorption Therapy for Patients With Non-Ischemic Dilated Cardiomyopathy (DCM)
Pilot Study of Immunoadsorption Therapy for Patients With Chronic Non-Ischemic Dilated Cardiomyopathy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Asahi Kasei Medical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the clinical safety and feasibility of Mysorba in patients with chronic non-ischemic dilated cardiomyopathy (DCM).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mysorba | Subjects will undergo one cycle of five immunoadsorption (IA) treatment sessions over two weeks. |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2011-11-23
- Last updated
- 2013-02-15
- Results posted
- 2013-02-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01478087. Inclusion in this directory is not an endorsement.